Showing results (3531-3540 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|February 24, 2001
Cyclooxygenases in the central nervous system: implications for treatment of neurological disordersA Yermakova, M K O'BanionCurrent Pharmaceutical Design|March 20, 2001
The nuclear receptors FXR and LXRalpha: potential targets for the development of drugs affecting lipid metabolism and neoplastic diseasesE J Niesor, J Flach, I Lopes-Antoni, et al.Current Pharmaceutical Design|March 20, 2001
Pharmacological interference with transcriptional control of osteoblasts: a possible role for leptin and fatty acids in maintaining bone strength and body lean massJ O Gordeladze, J E Reseland, C A DrevonCurrent Pharmaceutical Design|March 20, 2001
Helicobacter pylori: current chemotherapy and new targets for drug designJ S WilliamsonCurrent Pharmaceutical Design|May 29, 2001
Identification of the descriptor pharmacophores using variable selection QSAR: applications to database miningA Tropsha, W ZhengCurrent Pharmaceutical Design|May 29, 2001
Molecular mechanisms of ligand recognition by parathyroid hormone 1 (PTH1) and PTH2 receptorsS R Hoare, T B UsdinCurrent Pharmaceutical Design|May 29, 2001
The role of metabolism and toxicokinetics in retinoid teratogenesisG Tzimas, H NauCurrent Pharmaceutical Design|May 29, 2001
Delayed developmental effects following prenatal exposure to drugsA Mantovani, G CalamandreiCurrent Pharmaceutical Design|February 7, 2003
Study of atrazine effects on Pacific oyster, Crassostrea gigas, haemocytesB Gagnaire, T Renault, K Bouilly, et al.Current Pharmaceutical Design|February 7, 2003
Cytokines in the pathogenesis of chronic obstructive pulmonary diseaseP T Reid, J-M SallenavePageof 1,008